Here's Why Hims & Hers Health, Inc. (HIMS) is a Strong Momentum Stock
Yahoo Financearrow_outwardHow Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS)
Seeking Alphaarrow_outwardHims soars on quiet news day with call activity ramping
Sherwood Newsarrow_outwardINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
Morningstararrow_outwardWhat drives HIMS stock price - Extraordinary profit generation - Autocar Professional
Autocar Professionalarrow_outwardIs Hims & Hers the Newest Meme Stock Darling? - 24/7 Wall St.
24/7 Wall St.arrow_outwardHims & Hers Health, Inc. Class Action: The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS - Barchart.com
Barchart.comarrow_outwardHIMS STOCK NEWS: Hims & Hers Health, Inc. (NYSE:HIMS) is - GlobeNewswire
GlobeNewswirearrow_outwardDaily stock watch: Tesla, Alphabet, Chipotle, IBM, Hims & Hers Health - MSN
MSNarrow_outward5 stocks people are talking about on Thursday - Business Insider
Business Insiderarrow_outward10 Stocks With Eye-Popping Double-Digit Gains - Insider Monkey
Insider Monkeyarrow_outwardHims stock jumps 12% but faces major analyst skepticism - Rolling Out
Rolling Outarrow_outwardWhat's Going On With Hims & Hers Stock Wednesday? - Benzinga
Benzingaarrow_outwardGrowth or Bubble? Hims & Hersโ Stock Surge Unveiled - StocksToTrade
StocksToTradearrow_outwardHims stock soars 12% on earning hype but analysts still urge caution: hereโs why - Invezz
Invezzarrow_outwardHims & Hers Health Stock (HIMS) Opinions on Telehealth Disruption and Growth - Nasdaq
Nasdaqarrow_outwardThe Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well - TradingView
TradingViewarrow_outwardWhat analysts say about HIMS stock - Skyrocketing profit margins - jammulinksnews.com
Jammulinksnews.comarrow_outwardHims & Hers Paves the Way for Global Digital Health Expansion - Zacks Investment Research
Zacks Investment Researcharrow_outwardWhat You Can Learn From Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S After Its 26% Share Price Crash - simplywall.st
Simplywall.starrow_outwardHims & Hers Health (HIMS): Is This Volatile Disruptor a Strong Buy for the Future of Consumer Healthcare? - AInvest
AInvestarrow_outwardHims Stock at $50: Hereโs What Truist Expects Next - TipRanks
TipRanksarrow_outwardHow Novo Nordisk Rival Hims Became King of Knockoff Weight-Loss Drugs - Bloomberg
Bloombergarrow_outward$HIMS stock is up 7% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitativearrow_outwardIs Hims & Hers Stock in Trouble? - The Motley Fool
The Motley Foolarrow_outwardWhy Hims & Hers Is a Buy Below $35 After Its 16% Pullback - MarketBeat
MarketBeatarrow_outwardStocks on the Move: Hims & Hers Health and JetBlue - CNBC
CNBCarrow_outwardHIMS Stock To $25? - Forbes
Forbesarrow_outwardHims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug - Pharmaceutical Technology
Pharmaceutical Technologyarrow_outwardHims stock plunged 34%; Hereโs why - INDmoney
INDmoneyarrow_outwardHIMS Leveraged ETF Crashes 70% as Novo Ends Deal - ETF.com
ETF.comarrow_outwardHims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices - Investopedia
Investopediaarrow_outwardIBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs - Investor's Business Daily
Investor's Business Dailyarrow_outwardNovo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing - PR Newswire
PR Newswirearrow_outwardHims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup - WSJ - The Wall Street Journal
The Wall Street Journalarrow_outwardHims & Hersโ stock plunges after Wegovy parent ends weight-loss drug partnership - MarketWatch
MarketWatcharrow_outwardNovo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters
Reutersarrow_outwardHims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal - Fierce Healthcare
Fierce Healthcarearrow_outwardHims & Hers stock plummets after Novo Nordisk ends partnership over โknockoffโ Wegovy - Fast Company
Fast Companyarrow_outwardNovo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop - USA Today
USA Todayarrow_outwardHIMS stock news: Hims & Hers Stock Plunges 30% after partnership fallout - Markets.com
Markets.comarrow_outwardHims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership - Barron's
Barron'sarrow_outwardBuy, Sell, or Hold HIMS Stock? - Trefis
Trefisarrow_outward
Hims Stock close
- 2025-07-26 00:10 event
- 43 sourceslanguage
- 500+ ads_click
- 20 hours ago schedule